Ryan D Maynard Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ryan D Maynard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ryan D Maynard. Ryan D Maynard is EVP & CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and VP Finance, Acting CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in Lion Biotechnologies, Inc. ($LBIO).
Latest Insider Trading Transactions of Ryan D Maynard
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2020 | IOVA | IOVANCE BIOTHERAPE ... | Maynard Ryan D | Director | Option Exercise | A | 32.17 | 35,000 | 1,125,950 | 35,000 | |
| Jun 11 2019 | IOVA | IOVANCE BIOTHERAPE ... | Maynard Ryan D | Director | Option Exercise | A | 19.93 | 35,000 | 697,550 | 35,000 | |
| Jul 19 2018 | IOVA | IOVANCE BIOTHERAPE ... | Maynard Ryan D | Director | Option Exercise | A | 14.45 | 35,000 | 505,750 | 35,000 | |
| Nov 07 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 2.14 | 100,000 | 214,000 | 75,000 | |
| Nov 07 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 3.90 | 100,000 | 390,000 | 0 | 100 K to 0 (-100.00 %) |
| Nov 07 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 2.14 | 100,000 | 214,000 | 100,000 | 0 to 100 K |
| Jun 05 2017 | LBIO | Lion Biotechnologi ... | Maynard Ryan D | Director | Option Exercise | A | 5.45 | 35,000 | 190,750 | 35,000 | |
| Apr 21 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.74 | 150,000 | 411,000 | 150,000 | |
| Apr 21 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 3.59 | 62,500 | 224,375 | 62,500 | |
| Feb 06 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.11 | 150,000 | 316,500 | 150,000 | |
| Aug 18 2016 | LBIO | Lion Biotechnologi ... | Maynard Ryan D | Director | Option Exercise | A | 9.10 | 35,000 | 318,500 | 35,000 | |
| Aug 18 2016 | LBIO | Lion Biotechnologi ... | Maynard Ryan D | Director | Option Exercise | A | 9.10 | 35,000 | 318,500 | 35,000 | |
| Apr 06 2016 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.14 | 175,000 | 374,500 | 175,000 | |
| Apr 06 2016 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 3.59 | 62,500 | 224,375 | 62,500 | |
| Jan 28 2016 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.74 | 150,000 | 411,000 | 150,000 | |
| Jun 16 2015 | LBIO | Lion Biotechnologi ... | Maynard Ryan D | Director | Option Exercise | A | 11.05 | 35,000 | 386,750 | 35,000 | |
| Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP Finance, Acting ... | Option Exercise | A | 9.56 | 1,000 | 9,560 | 1,000 |
Page: 1